Metformin

A biguanide medication that lowers blood sugar levels primarily by decreasing glucose production in the liver and improving insulin sensitivity.

Voglibose

An alpha-glucosidase inhibitor that slows down the breakdown of carbohydrates in the gut, leading to a slower and more gradual rise in blood sugar after meals.

Type 2 diabetes mellitus, particularly in patients who are not adequately controlled with metformin alone.

Management of hyperglycemia (high blood sugar) in patients with type 2 diabetes.

Metformin reduces hepatic glucose production and enhances insulin sensitivity. Voglibose inhibits alpha-glucosidases in the small intestine, delaying carbohydrate absorption and reducing postprandial (after-meal) glucose spikes. The combination provides a synergistic effect on blood glucose control.

Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Dosage should be determined by a healthcare professional based on individual patient needs and response.

Typically, the medication is taken with meals to maximize its effect on postprandial glucose levels.

Always follow your doctor's instructions carefully.

Lactacidosis (a rare but serious complication; characterized by metabolic acidosis)

Hypoglycemia (low blood sugar) particularly when combined with other antidiabetic medications or insulin

Gastrointestinal disturbances (nausea, vomiting, diarrhea, abdominal pain)

Vitamin B12 deficiency

Allergic reactions (rash, itching, hives)

Alcohol Consumption

Alcohol consumption can increase the risk of lactic acidosis. Limit or avoid alcohol while taking this medication.



Driving or Operating Machinery

Hypoglycemia can impair cognitive function and reaction time. Avoid driving or operating machinery if experiencing hypoglycemia.



Pregnant & Breastfeeding Women

Generally not recommended during pregnancy and breastfeeding. Consult your doctor for advice.



Children

Not generally recommended for use in children.



Kidney

Metformin is contraindicated in patients with severe kidney disease. Dose adjustments may be necessary for patients with mild to moderate kidney impairment.



Liver

Caution is advised in patients with liver disease. Liver function tests may be monitored.

Consult your physician or pharmacist for specific references and detailed prescribing information.

The product monograph or package insert provided with your medication.